Does AMIVANTAMAB Cause Pleural effusion? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Pleural effusion have been filed in association with AMIVANTAMAB (Rybrevant). This represents 1.7% of all adverse event reports for AMIVANTAMAB.
13
Reports of Pleural effusion with AMIVANTAMAB
1.7%
of all AMIVANTAMAB reports
8
Deaths
12
Hospitalizations
How Dangerous Is Pleural effusion From AMIVANTAMAB?
Of the 13 reports, 8 (61.5%) resulted in death, 12 (92.3%) required hospitalization, and 4 (30.8%) were considered life-threatening.
Is Pleural effusion Listed in the Official Label?
Yes, Pleural effusion is listed as a known adverse reaction in the official FDA drug label for AMIVANTAMAB.
What Other Side Effects Does AMIVANTAMAB Cause?
Infusion related reaction (62)
Rash (61)
Pulmonary embolism (41)
Dermatitis acneiform (34)
Thrombocytopenia (33)
Paronychia (29)
Diarrhoea (25)
Pneumonitis (24)
Dyspnoea (23)
Nausea (23)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
NIVOLUMAB (1,061)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
Which AMIVANTAMAB Alternatives Have Lower Pleural effusion Risk?
AMIVANTAMAB vs AMIVANTAMAB-VMJW
AMIVANTAMAB vs AMLODIPINE
AMIVANTAMAB vs AMLODIPINE BESILATE
AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB vs AMLODIPINE\BENAZEPRIL